Semaglutide, which is similar to LG, has been reported to reduce levels of alanine aminotransferase and markers of inflammation (135) with the levels of inflammation biomarkers being significantly lower after it treatment
Gastrointestinal adverse events, primarily nausea, vomiting, diarrhea, and constipation, are the predominant side effects, occurring most frequently during dose escalation and generally diminishing with continued treatment
Whether you are stepping up from standard Epithalon or beginning your longevity protocol with the advanced formulation, you receive personalized physician-supervised care designed around your biology and goals
Specific genetic markers in the GLP1R gene (rs6923761), GIPR gene (rs1800437), and FTO gene (rs9939609) influence appetite regulation and weight loss capacity
reports grants from Conselho Nacional de Desenvolvimento Cientfico e Tecnolgico (CNPq), during the conduct of the study